Vaccitech begins Phase 1 clinical study of VTP-300 immunotherapeutic to treat chronic Hepatitis B

Read more

Gilead targets remdesivir supply for two million COVID-19 patients by year-end

Read more

Bayer close to glyphosate settlement worth $8-10 billion: German business daily

Read more

Pharma industry appreciates CBIC’s move to adopts paperless process

Read more

Elemental Impurity Analysis in Pharmaceuticals: Validating performance of an Agilent 7800 ICP MS

Read more

West Launches AccelTRA® RTS/RTU Product Line in India

Read more

Inovio gets $71 million from US defense department for COVID-19 vaccine device

Read more

Industry should come forward to develop Pharma and Medical Devices parks: Mansukh Mandaviya

Read more

Trials with Oxford COVID-19 vaccine start in Brazil

Read more

Gilead to commence trials of inhaled remdesivir

Read more